Article info

Download PDFPDF
Original research
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

Authors

  • Mathias Jachs Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Lukas Hartl Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Dunja Schaufler Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Christopher Desbalmes Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Benedikt Simbrunner Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, AustriaChristian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Ernst Eigenbauer IT4Science, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • David Josef Maria Bauer Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Rafael Paternostro Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Philipp Schwabl Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, AustriaChristian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Bernhard Scheiner Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Theresa Bucsics Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Albert Friedrich Stättermayer Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Matthias Pinter Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Michael Trauner Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Mattias Mandorfer Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Thomas Reiberger Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, AustriaVienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, AustriaChristian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Thomas Reiberger, Clinical Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; thomas.reiberger{at}meduniwien.ac.at
View Full Text

Citation

Jachs M, Hartl L, Schaufler D, et al
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

Publication history

  • Received August 3, 2020
  • Revised October 18, 2020
  • Accepted October 19, 2020
  • First published November 16, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.